Myasthenia gravis (MG), a typical autoimmune disease in neurology, imposes significant disease and medical burdens. In recent years, China has achieved remarkable progress in MG diagnosis and treatment, particularly with the introduction of various innovative drugs that have added effective therapeutic options for MG. To further enhance specialized exchanges among experts and scholars in the field of neuroimmunology and promote standardized and precision treatment of MG, the "Boundless Muscle Recovery - 2025 Neuroimmunology Frontline Innovation Academic Exchange Conference" was successfully held in Chengdu on September 19, 2025. Organized by the Chengdu High-Tech Medical Association, the conference invited renowned experts from within and outside the province to deliver lectures. The content covered theoretical research on neurology-related diseases, clinical hot topics, and analysis of classic practical cases, demonstrating strong progressiveness, practicality, and operability.